CPRX CATALYST PHARMACEUTICALS, INC.

8-K Current Report

Filed: February 25, 2026

Health Care

Pharmaceutical Preparations

CATALYST PHARMACEUTICALS, INC. (CPRX) 8-K current report filed with SEC EDGAR on February 25, 2026. This page provides AI-powered analysis of reported events and material disclosures, including results of operations, corporate governance changes, agreements, and other triggering events as disclosed under Form 8-K item codes.

Reported 8-K Items
1 item

Item 8.01: Other Events

AI Filing Analysis
8-K

Item 8.01 · Other Events

• Q4 and full-year 2025 earnings results disclosed alongside 2026 revenue guidance — details in Exhibit 99.1
• 2026 revenue guidance issuance signals management visibility into pipeline/commercial trajectory, a key catalyst for CPRX investors

+1 more insights

Other CATALYST PHARMACEUTICALS, INC. 8-K Filings

8-K Mar 19, 2026

8-K Mar 18, 2026

Get deeper insights on CATALYST PHARMACEUTICALS, INC.

Access full AI analysis, insider trading data, fund holdings, and cross-signal detection on SignalX.